Schleiss MR - Search Results

1

Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

Schleiss MR, Permar SR, Plotkin SA. Schleiss MR, et al. Clin Vaccine Immunol. 2017 Dec 5;24(12):e00268-17. doi: 10.1128/CVI.00268-17. Print 2017 Dec. Clin Vaccine Immunol. 2017. PMID: 29046308 Free PMC article. Review.

2

Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs.

Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, Bernstein DI. Bratcher DF, et al. Among authors: schleiss mr. J Infect Dis. 1995 Oct;172(4):944-50. doi: 10.1093/infdis/172.4.944. J Infect Dis. 1995. PMID: 7561214

3

Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.

Bourne N, Schleiss MR, Bravo FJ, Bernstein DI. Bourne N, et al. Among authors: schleiss mr. J Infect Dis. 2001 Jan 1;183(1):59-64. doi: 10.1086/317654. Epub 2000 Nov 21. J Infect Dis. 2001. PMID: 11087203

4

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.

Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S. Bernstein DI, et al. Among authors: schleiss mr. J Infect Dis. 2002 Mar 1;185(5):686-90. doi: 10.1086/339003. Epub 2002 Feb 6. J Infect Dis. 2002. PMID: 11865427 Clinical Trial.

5

Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV).

Schleiss MR. Schleiss MR. J Clin Virol. 2002 Aug;25 Suppl 2:S37-49. doi: 10.1016/s1386-6532(02)00100-2. J Clin Virol. 2002. PMID: 12361755 Review.

6

Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.

Schleiss MR, Bourne N, Bernstein DI. Schleiss MR, et al. J Infect Dis. 2003 Dec 15;188(12):1868-74. doi: 10.1086/379839. Epub 2003 Dec 9. J Infect Dis. 2003. PMID: 14673766

7

Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.

Schleiss MR, Bourne N, Stroup G, Bravo FJ, Jensen NJ, Bernstein DI. Schleiss MR, et al. J Infect Dis. 2004 Apr 15;189(8):1374-81. doi: 10.1086/382751. Epub 2004 Apr 1. J Infect Dis. 2004. PMID: 15073673

8

Antiviral therapy of congenital cytomegalovirus infection.

Schleiss MR. Schleiss MR. Semin Pediatr Infect Dis. 2005 Jan;16(1):50-9. doi: 10.1053/j.spid.2004.09.012. Semin Pediatr Infect Dis. 2005. PMID: 15685150 Review.

9

Progress toward an elusive goal: current status of cytomegalovirus vaccines.

Schleiss MR, Heineman TC. Schleiss MR, et al. Expert Rev Vaccines. 2005 Jun;4(3):381-406. doi: 10.1586/14760584.4.3.381. Expert Rev Vaccines. 2005. PMID: 16026251 Free article. Review.

10

Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?

Schleiss MR. Schleiss MR. Rev Med Virol. 2006 Mar-Apr;16(2):73-82. doi: 10.1002/rmv.484. Rev Med Virol. 2006. PMID: 16287195 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters